Biomarkers of oxidative stress in pregnancy complications

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Williams D. Pregnancy: a stress test for life. Curr. Opin. Obstet. Gynecol. 15(6), 465–471 (2003).
  MedlineGoogle Scholar
• 2 Cheong JN, Wlodek ME, Moritz KM, Cuffe JS. Programming of maternal and offspring disease: impact of growth restriction, fetal sex and transmission across generations. J. Physiol. 594(17), 4727–4740 (2016). • An important review which discusses the intergenerational cycle of pregnancy complications.
  Medline CASGoogle Scholar
• 3 Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ 325(7356), 157–160 (2002).
  MedlineGoogle Scholar
• 4 Kajantie E, Eriksson JG, Osmond C, Thornburg K, Barker DJ. Pre-eclampsia is associated with increased risk of stroke in the adult offspring: the Helsinki birth cohort study. Stroke 40(4), 1176–1180 (2009).
  MedlineGoogle Scholar
• 5 Villar J, Carroli G, Wojdyla D et al. Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am. J. Obstet. Gynecol. 194(4), 921–931 (2006).
  MedlineGoogle Scholar
• 6 Ben-Haroush A, Yogev Y, Hod M. Epidemiology of gestational diabetes mellitus and its association with Type 2 diabetes. Diabet. Med. 21(2), 103–113 (2004).
  Medline CASGoogle Scholar
• 7 Kane SC, Costa Fda S, Brennecke S. First trimester biomarkers in the prediction of later pregnancy complications. Biomed. Res. Int. 2014, 807196 (2014).
  MedlineGoogle Scholar
• 8 Norwitz ER. Defective implantation and placentation: laying the blueprint for pregnancy complications. Reprod. Biomed. Online 13(4), 591–599 (2006). • An important review on the role of defective implantation on the development of a number of pregnancy complications.
  Medline CASGoogle Scholar
• 9 Hahn S, Lapaire O, Than NG. Biomarker development for presymptomatic molecular diagnosis of preeclampsia: feasible, useful or even unnecessary? Expert Rev. Mol. Diagn. 15(5), 617–629 (2015).
  Medline CASGoogle Scholar
• 10 Burke HB. Predicting clinical outcomes using molecular biomarkers. Biomark. Cancer 8, 89–99 (2016).
  Medline CASGoogle Scholar
• 11 Pereira AC, Martel F. Oxidative stress in pregnancy and fertility pathologies. Cell Biol. Toxicol. 30(5), 301–312 (2014).
  Medline CASGoogle Scholar
• 12 Holdsworth-Carson SJ, Lim R, Mitton A et al. Peroxisome proliferator-activated receptors are altered in pathologies of the human placenta: gestational diabetes mellitus, intrauterine growth restriction and preeclampsia. Placenta 31(3), 222–229 (2010).
  Medline CASGoogle Scholar
• 13 Sanchez-Aranguren LC, Prada CE, Riano-Medina CE, Lopez M. Endothelial dysfunction and preeclampsia: role of oxidative stress. Front. Physiol. 5, 372 (2014).
  MedlineGoogle Scholar
• 14 Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin. Chem. 52(4), 601–623 (2006).
  Medline CASGoogle Scholar
• 15 Frijhoff J, Winyard PG, Zarkovic N et al. Clinical relevance of biomarkers of oxidative stress. Antioxid. Redox Signal. 23(14), 1144–1170 (2015).
  Medline CASGoogle Scholar
• 16 Ho E, Galougahi KK, Liu C-C, Bhindi R, Figtree GA. Biological markers of oxidative stress: applications to cardiovascular research and practice. Redox Biol. 1(1), 483–491 (2013).
  Medline CASGoogle Scholar
• 17 Kadiiska M, Gladen B, Baird D et al. Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl 4 poisoning? Free Radic. Biol. Med. 38(6), 698–710 (2005).
  Medline CASGoogle Scholar
• 18 Nagalla SR, Snyder CK, Michaels JE et al. Maternal serum biomarkers for risk assessment in gestational diabetes. A potential universal screening test to predict GDM status. Indian J. Endocrinol. Metab. 19(1), 155–159 (2015).
  Medline CASGoogle Scholar
• 19 Zusterzeel PLM, Mulder TPJ, Peters WHM, Wiseman SA, Steegers EaP. Plasma protein carbonyls in nonpregnant, healthy pregnant and preeclamptic women. Free Radic. Res. 33(5), 471–476 (2009).
  Google Scholar
• 20 Bernardi F, Guolo F, Bortolin T, Petronilho F, Dal-Pizzol F. Oxidative stress and inflammatory markers in normal pregnancy and preeclampsia. J. Obstet. Gynaecol. Res. 34(6), 948–951 (2008).
  Medline CASGoogle Scholar
• 21 Tsukimori K, Yoshitomi T, Morokuma S, Fukushima K, Wake N. Serum uric acid levels correlate with plasma hydrogen peroxide and protein carbonyl levels in preeclampsia. Am. J. Hypertens. 21(12), 1343–1346 (2008).
  Medline CASGoogle Scholar
• 22 Serdar Z, Gur E, Colakoethullary M, Develioethlu O, Sarandol E. Lipid and protein oxidation and antioxidant function in women with mild and severe preeclampsia. Arch. Gynecol. Obstet. 268(1), 19–25 (2003).
  Medline CASGoogle Scholar
• 23 Mihu D, Razvan C, Malutan A, Mihaela C. Evaluation of maternal systemic inflammatory response in preeclampsia. Taiwan. J. Obstet. Gynecol. 54(2), 160–166 (2015).
  MedlineGoogle Scholar
• 24 Parra M, Rodrigo R, Barja P et al. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. Am. J. Obstet. Gynecol. 193(4), 1486–1491 (2005).
  Medline CASGoogle Scholar
• 25 Llurba E, Gratacos E, Martin-Gallan P, Cabero L, Dominguez C. A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. Free Radic. Biol. Med. 37(4), 557–570 (2004).
  Medline CASGoogle Scholar
• 26 Gelisgen R, Genc H, Kayali R et al. Protein oxidation markers in women with and without gestational diabetes mellitus: a possible relation with paraoxonase activity. Diabetes Res. Clin. Pract. 94(3), 404–409 (2011).
  Medline CASGoogle Scholar
• 27 Pathak R, Suke SG, Ahmed T et al. Organochlorine pesticide residue levels and oxidative stress in preterm delivery cases. Hum. Exp. Toxicol. 29(5), 351–358 (2010).
  Medline CASGoogle Scholar
• 28 Pathak R, Mustafa MD, Ahmed T et al. Intra uterine growth retardation: association with organochlorine pesticide residue levels and oxidative stress markers. Reprod. Toxicol. 31(4), 534–539 (2011).
  Medline CASGoogle Scholar
• 29 Saker M, Mokhtari NS, Merzouk SA, Merzouk H, Belarbi B, Narce M. Oxidant and antioxidant status in mothers and their newborns according to birthweight. Eur. J. Obstet. Gyn. R. B. 141(2), 95–99 (2008).
  Medline CASGoogle Scholar
• 30 Weber D, Stuetz W, Bernhard W et al. Oxidative stress markers and micronutrients in maternal and cord blood in relation to neonatal outcome. Eur. J. Clin. Nutr. 68(2), 215–222 (2014).
  Medline CASGoogle Scholar
• 31 Harsem NK, Braekke K, Torjussen T, Hanssen K, Staff AC. Advanced glycation end products in pregnancies complicated with diabetes mellitus or preeclampsia. Hypertens. Pregnancy 27(4), 374–386 (2008).
  Medline CASGoogle Scholar
• 32 Yan JY, Jiang LL. Expression of advanced glycation end products in placenta and concentration in maternal and umbilical serum in pre-eclampsia. J. Obstet. Gynaecol. Res. 41(6), 843–849 (2015).
  Medline CASGoogle Scholar
• 33 Bartakova V, Kollarova R, Kuricova K, Sebekova K, Belobradkova J, Kankova K. Serum carboxymethyl-lysine, a dominant advanced glycation end product, is increased in women with gestational diabetes mellitus. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub. 160(1), 70–75 (2016).
  MedlineGoogle Scholar
• 34 Kharb S. Low whole blood glutathione levels in pregnancies complicated by preeclampsia and diabetes. Clin. Chim. Acta 294(1), 179–183 (2000).
  Medline CASGoogle Scholar
• 35 Sharma JB, Sharma A, Bahadur A, Vimala N, Satyam A, Mittal S. Oxidative stress markers and antioxidant levels in normal pregnancy and pre-eclampsia. Int. J. Gynaecol. Obstet. 94(1), 23–27 (2006).
  Medline CASGoogle Scholar
• 36 Funai EF, Mackenzie A, Kadner SS, Roque H, Lee MJ, Kuczynski E. Glutathione peroxidase levels throughout normal pregnancy and in pre-eclampsia. J. Matern. Fetal Neonatal Med. 12(5), 322–326 (2002).
  Medline CASGoogle Scholar
• 37 Peuchant E, Brun J-L, Rigalleau V et al. Oxidative and antioxidative status in pregnant women with either gestational or Type 1 diabetes. Clin. Biochem. 37(4), 293–298 (2004).
  Medline CASGoogle Scholar
• 38 Mehmetoglu I, Kurban S, Toker A et al. Serum ischemia-modified albumin and oxidized LDL in cord blood and serum of neonates born to pre-eclamptic mothers. Pediatr. Int. 57(3), 422–426 (2015).
  Medline CASGoogle Scholar
• 39 Ghaneei A, Yassini S, Ghanei ME, Shojaoddiny-Ardekani A. Increased serum oxidized low-density lipoprotein levels in pregnancies complicated by gestational diabetes mellitus. Iran J. Reprod. Med. 13(7), 421 (2015).
  MedlineGoogle Scholar
• 40 Aydemir B, Baykara O, Cinemre FB et al. LOX-1 gene variants and maternal levels of plasma oxidized LDL and malondialdehyde in patients with gestational diabetes mellitus. Arch. Gynecol. Obstet. 293(3), 517–527 (2016).
  Medline CASGoogle Scholar
• 41 Maisonneuve E, Delvin E, Edgard A et al. Oxidative conditions prevail in severe IUGR with vascular disease and Doppler anomalies. J. Matern. Fetal Neonatal Med. 28(12), 1471–1475 (2015).
  MedlineGoogle Scholar
• 42 Fruscalzo A, Londero AP, Biasizzo J et al. Second trimester amniotic fluid retinol in patients developing preeclampsia. Arch. Gynecol. Obstet. 291(4), 831–836 (2015).
  Medline CASGoogle Scholar
• 43 Morris JM, Gopaul NK, Endresen MJ et al. Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia. BJOG 105(11), 1195–1199 (1998).
  CASGoogle Scholar
• 44 Karowicz-Bilinska A, Kędziora-Kornatowska K, Bartosz G. Indices of oxidative stress in pregnancy with fetal growth restriction. Free Radic. Res. 41(8), 870–873 (2007).
  Medline CASGoogle Scholar
• 45 Ishihara O, Hayashi M, Osawa H et al. Isoprostanes, prostaglandins and tocopherols in pre-eclampsia, normal pregnancy and non-pregnancy. Free Radic. Res. 38(9), 913–918 (2004).
  Medline CASGoogle Scholar
• 46 Mckinney ET, Shouri R, Hunt RS, Ahokas RA, Sibai BM. Plasma, urinary, and salivary 8-epi-prostaglandin f2alpha levels in normotensive and preeclamptic pregnancies. Am. J. Obstet. Gynecol. 183(4), 874–877 (2000).
  Medline CASGoogle Scholar
• 47 Hsieh TT, Chen SF, Lo LM, Li MJ, Yeh YL, Hung TH. The association between maternal oxidative stress at mid-gestation and subsequent pregnancy complications. Reprod. Sci. 19(5), 505–512 (2012).
  MedlineGoogle Scholar
• 48 Qiu C, Hevner K, Abetew D, Enquobahrie DA, Williams MA. Oxidative DNA damage in early pregnancy and risk of gestational diabetes mellitus: a pilot study. Clin. Biochem. 44(10–11), 804–808 (2011). • An important pilot study which demonstrated a strong relationship between early urinary 8-oxo-7,8 dihydro-2 deoxyguanosine levels and the later development of gestational diabetes mellitus.
  Medline CASGoogle Scholar
• 49 Peter Stein T, Scholl TO, Schluter MD et al. Oxidative stress early in pregnancy and pregnancy outcome. Free Radical Res. 42(10), 841–848 (2008).
  Medline CASGoogle Scholar
• 50 Ferguson KK, Mcelrath TF, Chen Y-H, Loch-Caruso R, Mukherjee B, Meeker JD. Repeated measures of urinary oxidative stress biomarkers during pregnancy and preterm birth. Am. J. Obstet. Gynecol. 212(2), 208.e201–208.e208 (2015). •• This important prospective cohort study is a prime example of the type of study needed for validation of effective pregnancy disorder biomarkers. This study demonstrated that elevated urinary 8-isoprostane levels are predictive of preterm birth from as early as 10 weeks of gestation with increasing odds of spontaneous preterm birth with advancing gestation.
  Google Scholar
• 51 Suzuki YJ, Carini M, Butterfield DA. Protein carbonylation. Antioxid. Redox Signal. 12(3), 323–325 (2010).
  Medline CASGoogle Scholar
• 52 Dalle-Donne I, Rossi R, Giustarini D, Milzani A, Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta 329(1–2), 23–38 (2003).
  Medline CASGoogle Scholar
• 53 Vanderlelie J, Venardos K, Clifton VL, Gude NM, Clarke FM, Perkins AV. Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentae. Placenta 26(1), 53–58 (2005).
  Medline CASGoogle Scholar
• 54 Padmini E, Lavanya S, Uthra V. Preeclamptic placental stress and over expression of mitochondrial HSP70. Clin. Chem. Lab. Med. 47(9), 1073–1080 (2009).
  Medline CASGoogle Scholar
• 55 Zusterzeel PL, Rutten H, Roelofs HM, Peters WH, Steegers EA. Protein carbonyls in decidua and placenta of pre-eclamptic women as markers for oxidative stress. Placenta 22(2–3), 213–219 (2001).
  Medline CASGoogle Scholar
• 56 Chekir C, Nakatsuka M, Noguchi S et al. Accumulation of advanced glycation end products in women with preeclampsia: possible involvement of placental oxidative and nitrative stress. Placenta 27(2–3), 225–233 (2006).
  Medline CASGoogle Scholar
• 57 Cakatay U. Protein oxidation parameters in Type 2 diabetic patients with good and poor glycaemic control. Diabetes Metab. 31(6), 551–557 (2005).
  Medline CASGoogle Scholar
• 58 Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87(1), 315–424 (2007).
  Medline CASGoogle Scholar
• 59 Myatt L. Review: reactive oxygen and nitrogen species and functional adaptation of the placenta. Placenta 31(Suppl.), S66–S69 (2010).
  MedlineGoogle Scholar
• 60 Gelisgen R, Genc H, Kayali R et al. Protein oxidation markers in women with and without gestational diabetes mellitus: a possible relation with paraoxonase activity. Diabetes Res. Clin. Pract. 94(3), 404–409 (2011).
  Medline CASGoogle Scholar
• 61 Nowotny K, Jung T, Hohn A, Weber D, Grune T. Advanced glycation end products and oxidative stress in Type 2 diabetes mellitus. Biomolecules 5(1), 194–222 (2015).
  Medline CASGoogle Scholar
• 62 Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications. Korean J. Physiol. Pharmacol. 18(1), 1–14 (2014).
  Medline CASGoogle Scholar
• 63 Chen W, Zhang Y, Yue C et al. Accumulation of advanced glycation end products involved in inflammation and contributing to severe preeclampsia, in maternal blood, umbilical blood and placental tissues. Gynecol. Obstet. Invest. doi:10.1159/000448141 (2016) (Epub ahead of print).
  Google Scholar
• 64 Alexander KL, Mejia CA, Jordan C et al. Differential receptor for advanced glycation end products expression in preeclamptic, intrauterine growth restricted, and gestational diabetic placentas. Am. J. Reprod. Immunol. 75(2), 172–180 (2016).
  Medline CASGoogle Scholar
• 65 Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70(1), 158–169 (1967).
  Medline CASGoogle Scholar
• 66 Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27(3), 502–522 (1969).
  Medline CASGoogle Scholar
• 67 Deleve LD, Kaplowitz N. Glutathione metabolism and its role in hepatotoxicity. Pharmacol. Ther. 52(3), 287–305 (1991).
  Medline CASGoogle Scholar
• 68 Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. 27(3), 502–522 (1969).
  Medline CASGoogle Scholar
• 69 Zhong H, Yin H. Role of lipid peroxidation derived 4-hydroxynonenal (4-HNE) in cancer: Focusing on mitochondria. Redox Biol. 4, 193–199 (2015).
  Medline CASGoogle Scholar
• 70 Parthasarathy S, Raghavamenon A, Garelnabi MO, Santanam N. Oxidized low-density lipoprotein. Methods Mol. Biol. 610, 403–417 (2010).
  Medline CASGoogle Scholar
• 71 Pecks U, Caspers R, Sosnowsky K et al. [Determination of maternal and foetal serum lipid profile and placental oxidised low density lipoprotein accumulation in preeclampsia and normotensive pregnancies]. Z. Geburtshilfe Neonatol. 216(5), 220–225 (2012).
  Medline CASGoogle Scholar
• 72 Pecks U, Rath W, Caspers R et al. Oxidatively modified LDL particles in the human placenta in early and late onset intrauterine growth restriction. Placenta 34(12), 1142–1149 (2013).
  Medline CASGoogle Scholar
• 73 Vambergue A, Fajardy I. Consequences of gestational and pregestational diabetes on placental function and birth weight. World J. Diabetes 2(11), 196–203 (2011).
  MedlineGoogle Scholar
• 74 Weber D, Milkovic L, Bennett SJ, Griffiths HR, Zarkovic N, Grune T. Measurement of HNE-protein adducts in human plasma and serum by ELISA-comparison of two primary antibodies. Redox Biol. 1, 226–233 (2013).
  Medline CASGoogle Scholar
• 75 Luczaj W, Gindzienska-Sieskiewicz E, Jarocka-Karpowicz I et al. The onset of lipid peroxidation in rheumatoid arthritis: consequences and monitoring. Free Radic. Res. 50(3), 304–313 (2016).
  Medline CASGoogle Scholar
• 76 Lee WC, Wong HY, Chai YY et al. Lipid peroxidation dysregulation in ischemic stroke: plasma 4-HNE as a potential biomarker? Biochem. Biophys. Res. Commun. 425(4), 842–847 (2012).
  Medline CASGoogle Scholar
• 77 Chekir C, Nakatsuka M, Noguchi S et al. Accumulation of advanced glycation end products in women with preeclampsia: possible involvement of placental oxidative and nitrative stress. Placenta 27(2), 225–233 (2006).
  Medline CASGoogle Scholar
• 78 Navarro A, Alonso A, Garrido P et al. Increase in placental apolipoprotein D as an adaptation to human gestational diabetes. Placenta 31(1), 25–31 (2010).
  Medline CASGoogle Scholar
• 79 Temma K, Shimoya K, Zhang Q et al. Effects of 4-hydroxy-2-nonenal, a marker of oxidative stress, on the cyclooxygenase-2 of human placenta in chorioamnionitis. Mol. Hum. Reprod. 10(3), 167–171 (2004).
  Medline CASGoogle Scholar
• 80 Kweider N, Huppertz B, Wruck CJ et al. A role for Nrf2 in redox signalling of the invasive extravillous trophoblast in severe early onset IUGR associated with preeclampsia. PLoS ONE 7(10), e47055 (2012).
  Medline CASGoogle Scholar
• 81 Polhemus A, Moazamian R, Connaughton H et al. The cytotoxic effects of membrane lipid peroxidation products on human spermatozoa. Fertil. Steril. 104(3), e146 (2015).
  Google Scholar
• 82 Nielsen F, Mikkelsen BB, Nielsen JB, Andersen HR, Grandjean P. Plasma malondialdehyde as biomarker for oxidative stress: reference interval and effects of life-style factors. Clin. Chem. 43(7), 1209–1214 (1997).
  Medline CASGoogle Scholar
• 83 Bogavac M, Lakic N, Simin N, Nikolic A, Sudji J, Bozin B. Biomarkers of oxidative stress in amniotic fluid and complications in pregnancy. J. Matern. Fetal Neonatal Med. 25(1), 104–108 (2012).
  Medline CASGoogle Scholar
• 84 Montuschi P, Barnes PJ, Roberts LJ 2nd. Isoprostanes: markers and mediators of oxidative stress. FASEB J. 18(15), 1791–1800 (2004).
  Medline CASGoogle Scholar
• 85 Dexheimer TS. DNA repair pathways and mechanisms. In: DNA Repair Of Cancer Stem Cells. Lesley A Mathews, Stephanie M Cabarcas, Elaine Hurt (Eds). Springer, Dordrecht, The Netherlands, 19–32 (2013).
  Google Scholar
• 86 European Standards Committee on Urinary (DNA) Lesion Analysis, Evans MD, Olinski R, Loft S, Cooke MS. Toward consensus in the analysis of urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine as a noninvasive biomarker of oxidative stress. FASEB J. 24(4), 1249–1260 (2010).
  MedlineGoogle Scholar
• 87 Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin. Chim. Acta 339(1–2), 1–9 (2004).
  Medline CASGoogle Scholar
• 88 Morrow JD, Frei B, Longmire AW et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers—smoking as a cause of oxidative damage. N. Engl. J. Med. 332(18), 1198–1203 (1995).
  Medline CASGoogle Scholar
• 89 Li Z, Zeki R, Hilder L, Sullivan EA. Australia's mothers and babies 2011. Perinatal statistics series no. 28. Cat. no. PER 59. Canberra: AIHW National Perinatal Epidemiology and Statistics Unit (2013). • Highlights the immense opportunity for early prediction of pregnancy disorders given that most women have at least five antenatal visits with the first visit often before 14 weeks of pregnancy.
  Google Scholar